Sarah Stabenfeldt

Lower Motor Neuron Degeneration Following Traumatic Brain Injury

Determining how traumatic brain injury affects neurodegeneration will help design and target stem cell replacement therapies and improve quality of life.

Program: FURI

Size-Tunable Polymeric Nanoparticles for Drug Delivery after Traumatic Brain Injury

Designing novel drug delivery nanoparticles will help improve treatment and reduce the burden of neurological diseases.

Program: GCSP

Assessment of Injury Induced Blood Brain Barrier Disruption and Necroptosis via Development of Rapid Data Analysis Pipeline

A Java-based program can use individual pixel analysis to aid in quickly, efficiently and accurately analyzing stained tissue scan images.

Program: FURI

Assessment of Injury Induced Blood Brain Barrier Disruption and Necroptosis via Development of Rapid Data Analysis Pipeline

Creating and optimizing a Java program that allows characterization of traumatic brain injury in tissue samples will improve laboratory analysis efficiency.

Program: FURI

Utilizing Histone Deacetylase Inhibitors (HDACi) to Alleviate Traumatic Brain Injury (TBI) Pathology

Finding the most efficacious and potent HDAC inhibitor drug will help modulate neuroinflammation to improve traumatic brain injury pathology.

Program: MORE

The Effects on Lower Motor Neuron Degeneration and Neurodegeneration Within the Cervical Region of the Spinal Cord Twenty-Eight Days Post Traumatic Brain Injury

Collecting data to form a baseline for designing and targeting stem cell replacement therapies will mitigate the long-term effects of traumatic brain injury.

Program: FURI

Temporal Specificity of the Binding Potential of CDR3 Peptides to Traumatic Brain Injury

Discovering specific biomarkers for traumatic brain injury will aid in the diagnosis of the condition and pave the way for novel treatments.

Program: GCSP

Loperamide Encapsulated Nanoparticles for Evaluating Blood Brain Barrier Permeability Post-Experimental Traumatic Brain Injury

Evaluating nanoparticle use for therapeutic drug delivery will help better treat traumatic brain injury.

Program: MORE

Novel Nanoparticle System to Treat Traumatic Brain Injury

Designing novel nanoparticle systems will help alleviate underlying pathology following traumatic brain injury.

Program: FURI

Optimizing Recombinant Protein Production for Domain Antibodies: Proof-of-Concept

Optimizing nanoscale antibody protein production pipelines will help better treat traumatic brain injury and develop nanoparticle therapeutics.

Program: FURI

Nanoparticle Delivery through a Resection-Disrupted Blood Brain Barrier for the Treatment of Glioblastoma

Program: FURI

Human Neural Progenitor Cell Transplantation Sustainment and Maturation with Immunodeficient Mice

Program: FURI